Glucagon in beta blocker overdose
Pro Research Analysisby 
Searched over 200M research papers
Glucagon in Beta Blocker Overdose: A Comprehensive Review
Introduction to Beta Blocker Overdose and Glucagon
Beta blocker overdose is a critical condition that can lead to severe cardiovascular complications such as bradycardia, hypotension, and cardiogenic shock. Traditional treatments often fail to reverse these effects, necessitating alternative therapies. Glucagon has emerged as a potential antidote due to its unique mechanism of action that bypasses beta-adrenergic receptors, making it effective even in the presence of beta blockers 45.
Mechanism of Action of Glucagon
Glucagon exerts its effects by increasing cyclic AMP (cAMP) levels within the myocardium, leading to positive inotropic (increased heart contractility) and chronotropic (increased heart rate) effects. This mechanism is independent of beta-adrenergic receptors, which are blocked during beta blocker overdose, making glucagon a viable treatment option 48.
Clinical Evidence Supporting Glucagon Use
Case Reports and Series
Several case reports and series have documented the successful use of glucagon in treating severe beta blocker overdoses. For instance, two cases of profound beta blocker overdose were effectively managed with intravenous glucagon, demonstrating significant improvements in cardiovascular function 45. Another report highlighted the use of glucagon in a propranolol overdose case that did not respond to high-dose intravenous pressor agents but showed marked improvement with glucagon infusion .
Systematic Reviews and Meta-Analyses
A systematic review of animal studies found that glucagon consistently increased heart rate and cardiac output in beta blocker overdose models, although its effect on mean arterial pressure and survival rates was less clear . Another review aimed to consolidate findings from case series and reports to provide a more comprehensive understanding of glucagon's efficacy in human cases of beta blocker overdose .
Randomized Clinical Trials
A randomized clinical trial investigated the hemodynamic effects of high-dose glucagon in healthy men, both with and without beta blockade. The study found that glucagon significantly increased heart rate, systolic and diastolic blood pressure, and cardiac output, regardless of beta blockade. These effects were more sustained with glucagon infusion compared to bolus injections, suggesting that continuous infusion may be preferable .
Practical Considerations and Recommendations
Dosage and Administration
The recommended dosage for glucagon in beta blocker overdose is a 50 micrograms/kg intravenous loading dose, followed by a continuous infusion of 1-15 mg/h, titrated to patient response . Monitoring for side effects such as nausea, vomiting, hypokalemia, and hyperglycemia is essential .
Prehospital and In-Hospital Management
Given the critical nature of beta blocker overdose, early administration of glucagon by paramedics could be beneficial. Paramedics are trained in intravenous access and could potentially administer glucagon as a prehospital intervention, improving patient outcomes .
Conclusion
Glucagon has shown promise as an effective treatment for beta blocker overdose, with multiple case reports, systematic reviews, and clinical trials supporting its use. Its unique mechanism of action, independent of beta-adrenergic receptors, makes it a valuable antidote in cases where traditional treatments fail. While more human studies are needed to fully establish its efficacy, current evidence suggests that glucagon should be considered a first-line treatment in severe beta blocker overdose cases.
Sources and full results
Most relevant research papers on this topic
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Glucagon for the treatment of symptomatic beta blocker overdose.
Intravenous glucagon can support blood pressure in beta blocker overdose patients, as supported by six best evidence papers.
PROTOCOL OF A SYSTEMATIC REVIEW AND METAANALYSIS OF CASE-SERIES AND CASE-REPORTS INVOLVING GLUCAGON IN BETA-BLOCKER OVERDOSE
This study aims to conduct a systematic review of glucagon outcomes in beta-blocker overdose cases, aiming to fill the gap in research on this topic.
DOI